Numan
United Kingdom
- London, England
- 07/02/2022
- Series B
- $60,100,000
We're on a mission to fix ill health for men where they feel it most. It’s a decades-old problem: men aren’t seeking the healthcare that they need. Our survey revealed that 4 out of 10 men haven’t visited a doctor in over a year, and 1 out of 10 can’t even remember the last time they saw a doctor. We help solve the issues that men often leave untreated - not the life-threatening stuff, but the kinds of health problems that can be swept under the rug and may not be outwardly visible.
We're a digital health platform for men - providing access to expert advice, medication, diagnostics and supplements.
At Numan, we help men do something about their health, and live longer, healthier lives.
- Industry Wellness and Fitness Services
- Website https://www.numan.com/
- LinkedIn https://www.linkedin.com/company/numan-com/about/
Related People
Sokratis PapafloratosFounder
United Kingdom -
London, England
Technology entrepreneur and angel investor.
Parhelia Biosciences | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
Prove | $40,000,000 | (Oct 18, 2023)
Reality Defender | $15,000,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Nucleus RadioPharma | $56,000,000 | (Oct 18, 2023)
Society Brands | $25,000,000 | (Oct 18, 2023)
Nova Credit | $45,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
Zelus Analytics | Undisclosed Amount | (Oct 18, 2023)
Scorability | $11,000,000 | (Oct 18, 2023)